UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000018089 |
|---|---|
| Receipt number | R000020937 |
| Scientific Title | Efficacy of sofosbuvir and ribavirin therapy in patients with genotype 2 hepatitis C virus: Significance of variants associated with resistance in NS3, NS5A and NS5B region |
| Date of disclosure of the study information | 2015/06/26 |
| Last modified on | 2020/07/04 09:30:23 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/06/25 16:31:29 | ||
| 2 | Update | 2015/06/25 16:33:27 | Public title |
|
| 3 | Update | 2016/03/03 15:44:53 | Recruitment status |
|
| 4 | Update | 2017/12/27 08:38:19 | Name of primary person or sponsor Organization Category of Funding Organization Email1 |
|
| 5 | Update | 2018/08/28 07:44:53 | Recruitment status |
|
| 6 | Update | 2019/12/28 09:05:23 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 7 | Update | 2019/12/28 09:07:45 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
| 8 | Update | 2020/07/04 09:30:00 | Number of participants that the trial has enrolled |
|
| 9 | Update | 2020/07/04 09:30:23 | Recruitment status |
